clinical_trials
Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes
Confidence86·multiple reportsImportance88NP-EVT-20261107-628645F
(MedPage Today) -- Lowering lipoprotein(a), or Lp(a), did not translate into better cardiovascular outcomes in a secondary prevention population, at least not with pelacarsen in the Lp(a) HORIZON trial. Among people with elevated lipoprotein(a...
Read the original at the primary source
Lp(a)-Lowering Pelacarsen Shows Huge Disconnect With Cardiovascular Outcomes
11/7/2026, 6:24:51 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —